«Let the patient revolution begin» est l’étrange titre d’un numéro et d’un éditorial du BMJ.[1] Etrange, car peut-on encore parler d’un commencement ? See on rms.medhyg.ch
My Presentation from Athens looking at 5 things digital can do to revolutionise pharmaceuticals (with a bit of Gil Scott Heron thrown in for good measure) […]
The consumer medical device market, from pedometers and personal scales to blood glucose monitors and cholesterol meters, will surpass $10 billion by 2017 globally thanks to […]
At EyeNetra, the startup he cofounded, goofy curiosities like plastic eyeballs line the shelves, and a 3-D printing machine whirs in the background. It’s printing out […]
Big pharmaceutical companies such as Pfizer (PFE), Merck (MRK) and Johnson & Johnson (JNJ) are banking on oncology and immunology drugs for their future growth. See […]